Creative Medical Technology Holdings Profit Margin

The latest profit margin for CELZ is -1920.66% as of March 2026. That compares with -435.0% in the prior-year period — down 341.5% year over year. That is below the sector sector average of 19.69%. Investors often review this figure alongside Creative Medical Technology Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, CELZ's profit margin moved from -435.0% to -1920.66% — a 341.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Creative Medical Technology Holdings's valuation or profitability profile.

Against its sector companies, CELZ currently prints -1920.66% for profit margin, while the sector average sits near 19.69%. That is roughly 975481.6% below the sector mean. Large gaps often invite a closer look at Creative Medical Technology Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Creative Medical Technology Holdings converts resources into returns. At -1920.66%, CELZ may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -435.0% in the prior-year period — down 341.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CELZ's profit margin (-1920.66%), review year-over-year change from -435.0%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.